Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Killer T-Cells | 7 | 2024 | 319 | 2.320 |
Why?
|
Immunity, Innate | 5 | 2024 | 3081 | 0.890 |
Why?
|
Lung Diseases, Interstitial | 3 | 2024 | 939 | 0.720 |
Why?
|
Standard of Care | 2 | 2021 | 567 | 0.690 |
Why?
|
Laboratories, Hospital | 1 | 2022 | 193 | 0.690 |
Why?
|
Immunologic Techniques | 1 | 2020 | 212 | 0.680 |
Why?
|
Heart Arrest | 4 | 2024 | 1516 | 0.680 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2024 | 1002 | 0.650 |
Why?
|
Intensive Care Units | 4 | 2021 | 3800 | 0.630 |
Why?
|
Access to Information | 1 | 2022 | 317 | 0.620 |
Why?
|
Health Care Rationing | 1 | 2021 | 436 | 0.600 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 500 | 0.550 |
Why?
|
Killer Cells, Natural | 4 | 2023 | 2210 | 0.540 |
Why?
|
Inflammation | 9 | 2024 | 10850 | 0.520 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1240 | 0.490 |
Why?
|
Sepsis | 2 | 2020 | 2606 | 0.490 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 790 | 0.490 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7425 | 0.460 |
Why?
|
Triage | 1 | 2021 | 996 | 0.460 |
Why?
|
Receptors, Interleukin-6 | 2 | 2023 | 226 | 0.420 |
Why?
|
Information Dissemination | 1 | 2021 | 1142 | 0.410 |
Why?
|
Antigens, CD1d | 3 | 2024 | 226 | 0.410 |
Why?
|
Leadership | 1 | 2022 | 1392 | 0.400 |
Why?
|
Reperfusion Injury | 1 | 2018 | 1042 | 0.390 |
Why?
|
Interferon-gamma | 1 | 2020 | 3160 | 0.380 |
Why?
|
Cytokines | 2 | 2024 | 7421 | 0.380 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1749 | 0.380 |
Why?
|
Critical Illness | 9 | 2023 | 2744 | 0.370 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2056 | 0.360 |
Why?
|
Immune Tolerance | 1 | 2020 | 2324 | 0.360 |
Why?
|
Immune System | 3 | 2021 | 799 | 0.350 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2024 | 340 | 0.340 |
Why?
|
Interleukin-13 | 4 | 2024 | 388 | 0.330 |
Why?
|
Critical Care | 2 | 2021 | 2712 | 0.330 |
Why?
|
Respirovirus Infections | 2 | 2008 | 51 | 0.320 |
Why?
|
Pulmonary Fibrosis | 2 | 2024 | 503 | 0.300 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2024 | 518 | 0.290 |
Why?
|
Transcription, Genetic | 2 | 2015 | 7599 | 0.270 |
Why?
|
Mice | 22 | 2024 | 81818 | 0.270 |
Why?
|
Lymphocytes | 3 | 2021 | 2599 | 0.270 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 3247 | 0.270 |
Why?
|
Connective Tissue Cells | 1 | 2016 | 50 | 0.260 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11888 | 0.260 |
Why?
|
Lung | 9 | 2024 | 10033 | 0.260 |
Why?
|
Ritonavir | 2 | 2023 | 330 | 0.250 |
Why?
|
Genomics | 2 | 2020 | 5929 | 0.240 |
Why?
|
Sulfoglycosphingolipids | 1 | 2024 | 32 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.230 |
Why?
|
Arthritis, Rheumatoid | 4 | 2024 | 3733 | 0.230 |
Why?
|
Asthma | 6 | 2019 | 6270 | 0.230 |
Why?
|
Blood Cells | 1 | 2016 | 307 | 0.220 |
Why?
|
Heparin | 2 | 2021 | 1630 | 0.220 |
Why?
|
Basophils | 1 | 2016 | 392 | 0.220 |
Why?
|
Thrombosis | 3 | 2022 | 2949 | 0.220 |
Why?
|
Signal Transduction | 7 | 2024 | 23600 | 0.210 |
Why?
|
Anticoagulants | 5 | 2023 | 4862 | 0.210 |
Why?
|
Virus Diseases | 5 | 2009 | 718 | 0.210 |
Why?
|
Immunogenetics | 1 | 2012 | 62 | 0.200 |
Why?
|
Mice, Inbred C57BL | 14 | 2024 | 22331 | 0.200 |
Why?
|
Hospitalization | 2 | 2023 | 10808 | 0.200 |
Why?
|
Synovial Membrane | 2 | 2022 | 513 | 0.200 |
Why?
|
Animals | 29 | 2024 | 168759 | 0.190 |
Why?
|
Gastric Juice | 1 | 2021 | 59 | 0.190 |
Why?
|
Macrophages, Alveolar | 2 | 2019 | 413 | 0.190 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 2770 | 0.190 |
Why?
|
Allergy and Immunology | 1 | 2012 | 169 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 637 | 0.180 |
Why?
|
Hemorrhage | 5 | 2022 | 3461 | 0.170 |
Why?
|
Resuscitation | 1 | 2024 | 679 | 0.170 |
Why?
|
Spleen | 1 | 2016 | 2296 | 0.170 |
Why?
|
Bayes Theorem | 4 | 2023 | 2354 | 0.170 |
Why?
|
Humans | 42 | 2024 | 765956 | 0.170 |
Why?
|
Adaptive Immunity | 1 | 2024 | 734 | 0.160 |
Why?
|
Respiratory Mucosa | 4 | 2007 | 438 | 0.160 |
Why?
|
Candida | 1 | 2020 | 172 | 0.160 |
Why?
|
Fibroblasts | 3 | 2024 | 4159 | 0.160 |
Why?
|
Palmitic Acid | 1 | 2019 | 147 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2022 | 552 | 0.160 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1882 | 0.160 |
Why?
|
Mast Cells | 1 | 2016 | 1412 | 0.150 |
Why?
|
Receptors, Purinergic P2 | 1 | 2019 | 149 | 0.150 |
Why?
|
Renin-Angiotensin System | 1 | 2023 | 737 | 0.150 |
Why?
|
Isoflurane | 1 | 2021 | 384 | 0.150 |
Why?
|
Leukotrienes | 1 | 2019 | 232 | 0.150 |
Why?
|
Respiration, Artificial | 4 | 2022 | 2709 | 0.150 |
Why?
|
Mice, Knockout | 9 | 2021 | 14447 | 0.150 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2019 | 184 | 0.140 |
Why?
|
Antigens, Ly | 1 | 2019 | 296 | 0.140 |
Why?
|
Neutrophils | 2 | 2021 | 3776 | 0.140 |
Why?
|
Candidiasis | 1 | 2020 | 371 | 0.140 |
Why?
|
Hospital Mortality | 6 | 2021 | 5343 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1857 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 353 | 0.130 |
Why?
|
Anesthetics, Inhalation | 1 | 2021 | 573 | 0.130 |
Why?
|
Pulmonary Alveoli | 1 | 2019 | 664 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1061 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2023 | 1514 | 0.130 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 704 | 0.130 |
Why?
|
Early Growth Response Protein 2 | 1 | 2015 | 25 | 0.120 |
Why?
|
Pandemics | 4 | 2024 | 8701 | 0.120 |
Why?
|
Lung Diseases | 2 | 2019 | 1940 | 0.120 |
Why?
|
Nervous System Diseases | 1 | 2024 | 1660 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1574 | 0.110 |
Why?
|
Hydroxychloroquine | 2 | 2023 | 431 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1792 | 0.110 |
Why?
|
Sendai virus | 3 | 2008 | 22 | 0.110 |
Why?
|
Cells, Cultured | 7 | 2022 | 18973 | 0.100 |
Why?
|
Male | 20 | 2024 | 363691 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1327 | 0.100 |
Why?
|
Promoter Regions, Genetic | 2 | 2021 | 5786 | 0.100 |
Why?
|
MicroRNAs | 2 | 2021 | 3785 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4642 | 0.100 |
Why?
|
Respiratory System | 3 | 2005 | 559 | 0.100 |
Why?
|
Female | 17 | 2024 | 396101 | 0.100 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2015 | 506 | 0.100 |
Why?
|
Glycosphingolipids | 1 | 2011 | 72 | 0.090 |
Why?
|
Treatment Failure | 2 | 2021 | 2652 | 0.090 |
Why?
|
Patient Discharge | 2 | 2024 | 3461 | 0.090 |
Why?
|
Mucin 5AC | 2 | 2008 | 96 | 0.090 |
Why?
|
beta-Glucans | 1 | 2011 | 129 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3690 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3222 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9524 | 0.090 |
Why?
|
Hypersensitivity | 1 | 2019 | 1168 | 0.090 |
Why?
|
Aspergillus fumigatus | 1 | 2011 | 158 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2021 | 81515 | 0.080 |
Why?
|
Monocytes | 1 | 2019 | 2595 | 0.080 |
Why?
|
Aspergillosis | 1 | 2011 | 242 | 0.080 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2022 | 284 | 0.080 |
Why?
|
Receptors, IgE | 2 | 2009 | 374 | 0.080 |
Why?
|
Immunization, Passive | 1 | 2021 | 616 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1946 | 0.080 |
Why?
|
Middle Aged | 11 | 2024 | 223004 | 0.080 |
Why?
|
ABO Blood-Group System | 1 | 2021 | 380 | 0.080 |
Why?
|
Boston | 1 | 2022 | 9338 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3850 | 0.080 |
Why?
|
Cell Wall | 1 | 2011 | 420 | 0.080 |
Why?
|
Chemokines, CC | 2 | 2009 | 285 | 0.080 |
Why?
|
Models, Immunological | 2 | 2008 | 517 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4752 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 4913 | 0.080 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 655 | 0.070 |
Why?
|
Adult | 10 | 2024 | 223038 | 0.070 |
Why?
|
Smoking | 1 | 2024 | 9081 | 0.070 |
Why?
|
Mucins | 2 | 2008 | 567 | 0.070 |
Why?
|
Cell Separation | 2 | 2019 | 1718 | 0.070 |
Why?
|
Communication | 1 | 2022 | 3916 | 0.070 |
Why?
|
Autoantigens | 1 | 2011 | 883 | 0.070 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2021 | 857 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2009 | 4405 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3888 | 0.070 |
Why?
|
Mucoproteins | 1 | 2006 | 49 | 0.070 |
Why?
|
Aged | 8 | 2024 | 171114 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18294 | 0.060 |
Why?
|
Bronchiolitis, Viral | 1 | 2006 | 82 | 0.060 |
Why?
|
Proteomics | 3 | 2023 | 3910 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 29 | 0.060 |
Why?
|
Chloride Channels | 1 | 2006 | 221 | 0.060 |
Why?
|
Odds Ratio | 2 | 2021 | 9649 | 0.060 |
Why?
|
Paramyxoviridae Infections | 1 | 2004 | 57 | 0.060 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 545 | 0.060 |
Why?
|
Apoptosis | 3 | 2019 | 9514 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1880 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2011 | 1387 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 491 | 0.050 |
Why?
|
Epithelial Cells | 3 | 2019 | 3681 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 229 | 0.050 |
Why?
|
Logistic Models | 2 | 2021 | 13266 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15880 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2019 | 5881 | 0.050 |
Why?
|
Macrophages | 3 | 2019 | 5772 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 562 | 0.050 |
Why?
|
Metaplasia | 3 | 2007 | 326 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2024 | 1162 | 0.040 |
Why?
|
United States | 3 | 2024 | 72898 | 0.040 |
Why?
|
Ketones | 1 | 2021 | 183 | 0.040 |
Why?
|
Intubation, Gastrointestinal | 1 | 2021 | 167 | 0.040 |
Why?
|
Respiratory Tract Diseases | 1 | 2006 | 744 | 0.040 |
Why?
|
Aspirin | 1 | 2022 | 3134 | 0.040 |
Why?
|
Biology | 1 | 2012 | 293 | 0.040 |
Why?
|
Dermatophagoides farinae | 1 | 2019 | 19 | 0.040 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2019 | 22 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2023 | 651 | 0.040 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1481 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29921 | 0.040 |
Why?
|
Science | 1 | 2012 | 234 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2009 | 2747 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2570 | 0.040 |
Why?
|
Antigens, Dermatophagoides | 1 | 2019 | 101 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 345 | 0.040 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.040 |
Why?
|
Deoxyribose | 1 | 1998 | 7 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2022 | 2536 | 0.040 |
Why?
|
Carbon-Oxygen Lyases | 1 | 1998 | 8 | 0.040 |
Why?
|
Mice, Inbred BALB C | 4 | 2011 | 6220 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1866 | 0.040 |
Why?
|
DNA Polymerase beta | 1 | 1998 | 19 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1555 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2024 | 22222 | 0.040 |
Why?
|
Viral Load | 1 | 2007 | 3386 | 0.040 |
Why?
|
Brain | 1 | 2024 | 27178 | 0.040 |
Why?
|
Length of Stay | 1 | 2021 | 6485 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 4025 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2019 | 755 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2008 | 11022 | 0.030 |
Why?
|
Stomach | 1 | 2021 | 699 | 0.030 |
Why?
|
Biological Assay | 1 | 2019 | 627 | 0.030 |
Why?
|
Stromal Cells | 1 | 2022 | 1329 | 0.030 |
Why?
|
Peritonitis | 1 | 2019 | 369 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2008 | 12769 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1968 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59488 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2077 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4562 | 0.030 |
Why?
|
Chronic Disease | 3 | 2022 | 9347 | 0.030 |
Why?
|
Research | 1 | 2012 | 1975 | 0.030 |
Why?
|
Epigenomics | 1 | 2019 | 959 | 0.030 |
Why?
|
Antiviral Agents | 2 | 2021 | 3050 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3273 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1365 | 0.020 |
Why?
|
Allergens | 1 | 2019 | 1436 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6763 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 1998 | 1057 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 24283 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2717 | 0.020 |
Why?
|
Swine | 1 | 2021 | 5988 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39194 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7232 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1602 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10602 | 0.020 |
Why?
|
Binding Sites | 1 | 2019 | 6001 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2011 | 444 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2021 | 3606 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41647 | 0.020 |
Why?
|
Crohn Disease | 1 | 2022 | 2283 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3559 | 0.020 |
Why?
|
Time Factors | 2 | 2008 | 40065 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10070 | 0.020 |
Why?
|
Complement Pathway, Alternative | 1 | 2009 | 106 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9550 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2006 | 11640 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2011 | 962 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3401 | 0.020 |
Why?
|
Chromatin | 1 | 2019 | 2980 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13024 | 0.020 |
Why?
|
Cell Movement | 1 | 2019 | 5194 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2159 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10563 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9296 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2005 | 220 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1770 | 0.010 |
Why?
|
Chemokine CCL5 | 1 | 2005 | 213 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2005 | 425 | 0.010 |
Why?
|
DNA | 1 | 1998 | 7202 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2006 | 752 | 0.010 |
Why?
|
Bronchial Hyperreactivity | 1 | 2006 | 300 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16721 | 0.010 |
Why?
|
Autoimmunity | 1 | 2011 | 1354 | 0.010 |
Why?
|
Hyperplasia | 1 | 2006 | 1144 | 0.010 |
Why?
|
Viruses | 1 | 2006 | 371 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12807 | 0.010 |
Why?
|
Immunity, Mucosal | 1 | 2005 | 498 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2006 | 1216 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14071 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5501 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 1652 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18071 | 0.010 |
Why?
|
Deoxyribonuclease IV (Phage T4-Induced) | 1 | 1998 | 8 | 0.010 |
Why?
|
Transcription Factors | 1 | 2019 | 12131 | 0.010 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 1998 | 71 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2627 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5020 | 0.010 |
Why?
|
Virus Replication | 1 | 2005 | 2447 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15543 | 0.010 |
Why?
|
Bleomycin | 1 | 1998 | 491 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3796 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2005 | 1930 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74836 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 1008 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2878 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 65189 | 0.010 |
Why?
|
Cell Survival | 1 | 2005 | 5746 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2005 | 2132 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1998 | 2218 | 0.010 |
Why?
|
Kinetics | 1 | 1998 | 6274 | 0.010 |
Why?
|
DNA Repair | 1 | 1998 | 2048 | 0.010 |
Why?
|
DNA Damage | 1 | 1998 | 2457 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9249 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12403 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10261 | 0.000 |
Why?
|